Immuno-endocrinology laboratory

We work to prevent and cure type 1 and type 2 diabetes by targeting the inflammatory and metabolic pathways leading to pancreatic beta-cell failure. Ongoing projects define the transcriptional, translational and posttranslational responses of the pancreatic beta-cell to immune, inflammatory, metabolic and oxidative stress, with the aim of identifying novel therapeutic targets to be tested in preclinical models and clinical trials.

top picture































The Immuno-endocrinology lab has been granted more than DKK 32 million within the last 10 years.

The Immuno-endocrinology lab is supported by grants from a number of private and public foundations. Listed below is a selection of public and private funds the group has received within the last 5 years.

Logo Funding provider

The Danish Council for Independent Research

Danmarks Frie Forskningsfond

Novo Nordisk Foundation

Vissing Fonden

European Research Council

European Foundation for the Study of Diabetes and Lilly European Diabetes Research Programme
(EFSD/Lilly Programme)


Augustinus Fonden

Bjarne Jensens Fond

Kirsten og Freddy Johansens Fond

Poul og Erna Sehested Hansens Foundation


Dagmar Marshall Fond

Vera & Flemming Westerberg Foundation






























































Group leader Thomas Mandrup-Poulsen

Group Leader
Thomas Mandrup-Poulsen

Phone: +45 3033 0387 

Group members

Name Title Phone E-mail
Anniek Frederike Lubberding Postdoc +4535331566 E-mail
Carolin Rita Hõfner Guest Researcher   E-mail
Emil Zeng Skovhøj PhD Fellow   E-mail
Jette Bach Agergaard PhD Fellow +4524820413 E-mail
Michal Tomasz Marzec Associate Professor +4535331284 E-mail
Phillip Alexander Keller Andersen PhD Fellow +4535332795 E-mail
Seyed Mojtaba Ghiasi Guest Researcher +4535332535 E-mail